Home/Filings/4/0001415889-24-029406
4//SEC Filing

Krasney Karen 4

Accession 0001415889-24-029406

CIK 0001133869other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 9:25 AM ET

Size

10.1 KB

Accession

0001415889-24-029406

Insider Transaction Report

Form 4
Period: 2024-12-13
Krasney Karen
EVP, GENERAL COUNSEL
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-135,0000 total
    Exercise: $1.39Exp: 2026-06-02Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-13$1.39/sh+8,000$11,12028,047 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-133,0000 total
    Exercise: $1.39Exp: 2025-03-03Common Stock (3,000 underlying)
Footnotes (4)
  • [F1]This option was granted on March 3, 2015 and was previously covering 30,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
  • [F2]Shares vested 1/48th on the first day of each month commencing April 1, 2015.
  • [F3]This option was granted on June 2, 2016 and was previously covering 50,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
  • [F4]Shares vested 1/48th on the first day of each month commencing July 1, 2016.

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001593086

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:25 AM ET
Size
10.1 KB